OP Asset Management Ltd Purchases New Shares in Sotera Health Company $SHC

OP Asset Management Ltd purchased a new position in Sotera Health Company (NASDAQ:SHC) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 116,345 shares of the company’s stock, valued at approximately $1,668,000.

Other large investors also recently added to or reduced their stakes in the company. IFP Advisors Inc grew its position in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC purchased a new stake in shares of Sotera Health during the fourth quarter worth about $27,000. True Wealth Design LLC raised its position in shares of Sotera Health by 389.3% during the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after purchasing an additional 1,456 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. purchased a new position in Sotera Health in the 4th quarter valued at about $40,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 15.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on SHC shares. Weiss Ratings cut Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. The Goldman Sachs Group began coverage on Sotera Health in a research report on Friday, June 5th. They issued a “buy” rating and a $20.00 target price on the stock. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. UBS Group set a $19.00 price target on Sotera Health in a research report on Wednesday. Finally, Barclays increased their price objective on Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research note on Wednesday. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $17.38 on Monday. The stock has a market cap of $4.96 billion, a PE ratio of 42.39 and a beta of 1.79. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. Sotera Health Company has a 12-month low of $10.93 and a 12-month high of $19.85. The company has a 50-day moving average of $15.79 and a 200 day moving average of $16.32.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business’s revenue was up 10.0% on a year-over-year basis. During the same period last year, the company posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, sell-side analysts predict that Sotera Health Company will post 0.88 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.